Anaesthesia · Chronic Pain Medicine and Palliative/Cancer Pain

Which of the following best describes the mechanism of action of gabapentinoids (gabapentin, pregabalin) in neuropathic pain?

  • A Blockade of sodium channels in peripheral nociceptors
  • B Competitive antagonism at NMDA glutamate receptors in the dorsal horn
  • C Inhibition of COX-2 enzyme in central sensitisation pathways
  • D Binding to the α2δ subunit of voltage-gated calcium channels, reducing excitatory neurotransmitter release in spinal dorsal horn
Correct answer: D. Binding to the α2δ subunit of voltage-gated calcium channels, reducing excitatory neurotransmitter release in spinal dorsal horn

Explanation

Gabapentin and pregabalin bind to the α2δ-1 subunit of voltage-gated calcium channels in primary afferent terminals and spinal dorsal horn neurons. This reduces calcium influx, thereby decreasing the release of excitatory neurotransmitters (glutamate, substance P, CGRP) at synapses — attenuating central sensitisation and allodynia. They are first-line agents for neuropathic pain (diabetic neuropathy, post-herpetic neuralgia, fibromyalgia) and perioperative opioid-sparing. They are NOT sodium channel blockers (that is the mechanism of local anaesthetics and anticonvulsants like carbamazepine). Ketamine is the NMDA antagonist.

Reference: Morgan & Mikhail's Clinical Anesthesiology, 6th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Chronic Pain Medicine and Palliative/Cancer Pain MCQs

See all Chronic Pain Medicine and Palliative/Cancer Pain MCQs →